Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “ras”

843 pharma patents match "ras" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 843
Index total 30,257
Page 18 / 36

Quick answer

This filtered view shows 843 pharmaceutical patents matching "ras" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

843 results for “ras” · 30,257 patents in full index Clear search

  1. US 9505719

    Synthesis and use of kinase inhibitors

    VERASTEM, INC. · Granted Nov 29, 2016 · Expires Nov 24, 2036

    granted

  2. US 9499495

    Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways

    Asana BioSciences, LLC · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted

  3. US 9498533

    Drug delivery compositions and methods

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted

  4. US 9492480

    Iron oxide nanoparticles for use in treating non-infectious inflammatory disorders

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted

  5. US 9492452

    Methods and compositions for inhibition of polymerase

    BioCryst Pharmaceuticals, Inc. · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted

  6. US 9486424

    Creatine oral supplementation using creatine hydrochloride salt

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted

  7. US 9481894

    Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Nov 1, 2016 · Expires Oct 27, 2036

    granted

  8. US 9474730

    Methods and compositions for use with K-ras mediated disorders

    The Board of Regents of the University of Texas System · Granted Oct 25, 2016 · Expires Oct 20, 2036

    granted

  9. US 9463233

    Avirulent, immunogenic flavivirus chimeras

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 11, 2016 · Expires Oct 6, 2036

    granted

  10. US 9457030

    Compositions and methods for the treatment of juvenile neuronal ceroid lipofuscinosis and related disorders

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Oct 4, 2016 · Expires Sep 29, 2036

    granted

  11. US 9453220

    RNAi-mediated inhibition of phosphodiesterase type 4 for treatment of cAMP-related ocular disorders

    Arrowhead Pharmaceuticals, Inc. · Granted Sep 27, 2016 · Expires Sep 22, 2036

    granted

  12. CA 2977090

    FORMULATIONS PHARMACEUTIQUES DE L'INHIBITEUR D'ESTERASE C1

    CSL BEHRING GMBH [DE] · Granted Aug 25, 2016 · Expires Aug 20, 2036

    granted

  13. US 9415123

    Polymeric nanoparticles for ultrasound imaging and therapy

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 16, 2016 · Expires Aug 11, 2036

    granted

  14. US 9403911

    Compositions and methods for detection and treatment of cancer

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted

  15. US 9394569

    Methods and kits for early detection of cancer or predisposition thereto

    The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted

  16. US 9375402

    Oral formulations of kinase inhibitors

    VERASTEM, INC. · Granted Jun 28, 2016 · Expires Jun 23, 2036

    granted

  17. US 9364443

    Compositions and methods for drug delivery

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted

  18. US 9345790

    Cobalt-based MRI contrast agent and imaging system

    The Board of Regents of the University of Texas System · Granted May 24, 2016 · Expires May 19, 2036

    granted

  19. US 9328200

    Branched polymeric quaternary ammonium compounds and their uses

    ULTRASCI DISCOVERY LLP · Granted May 3, 2016 · Expires Apr 28, 2036

    granted

  20. US 9328142

    Lipopeptide inhibitors of RAS oncoproteins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 3, 2016 · Expires Apr 28, 2036

    granted

  21. US 9320814

    Polyplexes of hydrophobically-modified siRNA for delivery of siRNA

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted

  22. US 9321811

    Further novel anti-parasitic compounds

    The Regents of the University of California · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted

  23. US 9314517

    Parasite vaccine

    The Board of Regents of the University of Texas System · Granted Apr 19, 2016 · Expires Apr 14, 2036

    granted

  24. US 9315534

    Radiologic agents for monitoring alzheimer's disease progression and Evaluating a Response to Therapy and processes for the preparation of such agents

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Apr 19, 2016 · Expires Apr 14, 2036

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.